The company was founded in August 2009 with the current registered capital of approx. 40 mil. USD. Siam Bioscience was founded by the following two organizations who share the same vision and mission for improving quality of life of the patients and for bridging the gap between research and commercialization. Crown Property Bureau Equity Co., Ltd. (CPBE) A subsidiary of Crown Property Bureau of Thailand, a Thai Government Agency which is responsible for managing the royal assets and property as well as supporting other activities for the benefits of Thai subjects and society
Mahidol University (MU): The leading research university in Thailand with strong research expertise in medicines, biomedical sciences, and biotechnology. Mahidol University provides technical personnel and existing infrastructure relevant for biopharmaceutical industry R&D and translational activities to Siam Bioscience Co., Ltd.
